Delivery Order V797P5878X-V501D60056
Award Date 9/22/06
Potential Completion Date 3/15/07
Potential Value $927K
Funding Federal Agency
Not listed Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not listed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency has awarded a $20,639.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. This non-set-aside contract was awarded on January 5, 2026, with an ultimate completion date of January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant medication commonly prescribed for rheumatoid arthritis and other...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,396.39 for ENBREL 50 mg/mL syringes on April 24, 2025, with completion scheduled for April 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant used to treat rheumatoid arthritis, psoriasis, and other inflammatory...
- The Defense Logistics Agency awarded a $25,050.69 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with a completion date of June 23, 2025. This non-competitive delivery order represents a firm fixed price purchase executed on June 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant medication commonly used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $49,259.33 to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant commonly used to treat rheumatoid arthritis,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of ENBREL 50 mg/mL SureClick auto-injectors with a ceiling value of $40,381.32 under a firm fixed-price contract. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $4,863.18 to AmerisourceBergen Drug Corp for the supply of ENBREL 25 mg/0.5 mL syringes on November 17, 2025, with an ultimate completion date of November 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. ENBREL is a TNF inhibitor used to treat rheumatoid arthritis, psoriasis, and other...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,093,165 units of Enbrel 50 mg/ml syringe, a medication used to treat autoimmune disorders. The contract has a ceiling value of $4,787.86 and a period of performance through May 1, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a substantial...
- The Defense Logistics Agency awarded a $10,244.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with performance to be completed by January 12, 2026. This non-set-aside award was competitively executed on January 9, 2026, with performance taking place at the awardee's facility in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant used to treat autoimmune conditions including rheumatoid arthritis,...
- The Defense Logistics Agency awarded a $25,836.74 delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency Troop Support Medical awarded a $7,197.57 delivery order contract to Amerisourcebergen Drug Corporation for the provision of 50 mg/ml syringes of etanercept, marketed under the brand name Enbrel. The contract has a firm fixed price and requires delivery to a facility located in Conshohocken, Pennsylvania, with performance spanning from July 27, 2023 to July 28, 2023. As the Defense Logistics Agency manages the global supply chain for the U.S. Department of Defense,...